Nephrectomy — How It Works, Benefits & Recovery — Procedure Guide, Recovery & Risks | MyMedicPlus

Nephrectomy is the surgical removal of all or part of a kidney performed for oncological, functional, or transplantation-related indications. Radical nephrectomy removes the entire kidney, Gerota's fascia (the fibrous layer surrounding the kidney), and in selected cases the ipsilateral adrenal gland and regional lymph nodes. Partial nephrectomy (nephron-sparing surgery) removes only the tumour and a margin of normal renal parenchyma, preserving the remaining functional kidney tissue. The laparoscopic approach — either transperitoneal (through the abdominal cavity) or retroperitoneal (directly through the flank) — has become standard for most nephrectomies, offering equivalent oncological outcomes to open surgery with significantly faster recovery. Robotic-assisted laparoscopic nephrectomy, particularly for complex partial nephrectomy requiring precise tissue dissection and intracorporeal suturing, is increasingly performed at specialist centres. Open radical nephrectomy through a flank incision (subcostal, supracostal) or midline incision remains the approach for very large tumours (>10 cm), tumours with inferior vena cava (IVC) thrombus, and selected revision surgery. Nephrectomy for living kidney donation uses a hand-assisted or pure laparoscopic retroperitoneal approach with meticulous attention to renal vascular pedicle length and warm ischaemia time minimisation.

This treatment represents an important component of modern medical management, supported by clinical evidence from multiple randomised controlled trials and systematic reviews. Treatment protocols are continually refined based on emerging evidence to optimise patient outcomes while minimising treatment burden.

Patient suitability is assessed through a structured multidisciplinary evaluation incorporating clinical history, physical examination findings, and results of relevant investigations. Treatment planning considers the full clinical context including disease characteristics, patient comorbidities, functional status, and individual treatment goals to ensure the most appropriate therapeutic approach is selected for each patient.

Nephrectomy is indicated across several clinical scenarios. Oncological indications: renal cell carcinoma (RCC) is the most common indication — clear cell, papillary, and chromophobe subtypes; radical nephrectomy for T2–T3 RCC (tumours >7 cm, involving Gerota's fascia or renal vein, or IVC thrombus) where partial nephrectomy is not technically feasible; partial nephrectomy (nephron-sparing surgery) is the preferred approach for T1 RCC (tumours ≤7 cm) when technically achievable — EAU guidelines mandate this when technically feasible to preserve renal function; radical nephrectomy for transitional cell carcinoma of the renal pelvis (RCC with ureterectomy). Non-oncological indications: non-functioning kidney from chronic obstruction, chronic pyelonephritis with recurrent infections, renal tuberculosis with calcification, or renovascular hypertension unresponsive to treatment; symptomatic polycystic kidneys with mass effect or recurrent infection; renal trauma with uncontrollable haemorrhage. Donation nephrectomy: healthy living kidney donors undergoing laparoscopic nephrectomy to provide a kidney for a compatible recipient. Pre-operative staging includes CT of chest, abdomen, and pelvis; isotope split renal function study (DMSA or MAG3 scan) to quantify contribution of each kidney to total function.

Laparoscopic radical nephrectomy: under general anaesthesia, the patient is positioned in the lateral decubitus flank-up position. Three to four laparoscopic ports are placed in the flank. The colon is reflected medially (transperitoneal) or Gerota's fascia approached directly (retroperitoneoscopic). The renal hilum is identified and the renal artery is clipped and divided first — prioritising arterial control before venous to reduce blood loss. The renal vein is then clipped and divided. The ureter is divided in the lower abdomen. Gerota's fascia and all adipose tissue surrounding the kidney are included in the specimen. The kidney is placed in an endoscopic extraction bag and removed through a slightly enlarged port site (Pfannenstiel or flank extension). Left renal vein surgery requires identification and preservation of the left gonadal and left adrenal veins. Laparoscopic partial nephrectomy: after hilar dissection, the renal artery is occluded with a laparoscopic bulldog clamp (warm ischaemia time should be <25–30 minutes). The tumour is excised with a 5–10 mm parenchymal margin using scissors or harmonic scalpel. The collecting system is repaired with absorbable sutures; the parenchymal defect is closed with haemostatic agents and renorrhaphy sutures. The warm ischaemia time is carefully timed and minimised to preserve post-operative renal function. Zero-ischaemia or early unclamping techniques are used in selected cases to further minimise functional impact.

Laparoscopic radical nephrectomy for T1–T2 renal tumours achieves 5-year cancer-specific survival of 90–95%, equivalent to open surgery with substantially better recovery profile. Hospital stay is 1–2 days for laparoscopic versus 5–7 days for open radical nephrectomy. Return to full activity is 2–3 weeks (laparoscopic) versus 6–8 weeks (open). For partial nephrectomy in T1a tumours (<4 cm), 5-year cancer-specific survival exceeds 97%, with a local recurrence rate of 1–3% — equivalent to radical nephrectomy. Preservation of 80–90% of nephron mass after partial nephrectomy significantly reduces long-term risk of chronic kidney disease (CKD) compared to radical nephrectomy (3× CKD risk reduction), cardiovascular morbidity, and all-cause mortality. Laparoscopic partial nephrectomy achieves oncological outcomes equivalent to open partial nephrectomy with faster recovery. Robotic-assisted partial nephrectomy reduces warm ischaemia times to 15–20 minutes in complex cases through enhanced dexterity, offering a significant advantage for hilar or complex tumour anatomy.

Intraoperative complications include haemorrhage from renal arterial or venous injury requiring transfusion in 2–5% of cases; inadvertent injury to adjacent structures (spleen, liver, bowel, pancreas, adrenal gland) requiring repair; pneumothorax from retroperitoneal approach tracking through the diaphragm (1%); and conversion to open surgery in 2–5% of laparoscopic cases. For partial nephrectomy: urine leak from the collecting system (urinary fistula) occurs in 2–4% and is usually managed with a ureteric stent and catheterisation for 4–6 weeks. Haemorrhage after partial nephrectomy requiring angioembolisation or reoperation occurs in 2–3%. Trocar-site hernia at 10–12 mm ports is reduced by fascial closure. Long-term functional consequences include chronic kidney disease (CKD) from reduced nephron mass after radical or partial nephrectomy — estimated glomerular filtration rate (eGFR) declines by 20–25% after radical nephrectomy (CKD stage 3 or 4 in 25–35% of patients with pre-existing borderline function), compared to 5–10% after partial nephrectomy. Annual eGFR monitoring, blood pressure control (<130/80 mmHg), avoidance of nephrotoxins, and lifestyle modification are essential for preserving long-term renal function.

Laparoscopic radical nephrectomy allows discharge in 1–2 days; laparoscopic partial nephrectomy in 2–3 days (catheter and drain are removed before discharge). Open surgery requires 3–5 days. A urethral catheter is removed on day 1 after radical nephrectomy. Oral analgesics (paracetamol, NSAIDs — used with caution in partial nephrectomy given renal function considerations) manage post-operative pain. Light activities resume within 1 week; driving at 2–3 weeks; return to desk work at 2–3 weeks; heavy physical work at 4–6 weeks. The remaining kidney undergoes compensatory hypertrophy over 3–6 months, increasing in size by 20–30% and improving GFR by 10–20%. Post-operative surveillance for RCC includes CT chest and abdomen at 3–6 months, then annually for 5 years (schedule varies by tumour stage and grade per EAU guidelines). Lifestyle advice for renal function preservation includes optimal blood pressure control, avoidance of NSAIDs and other nephrotoxins, smoking cessation, and maintaining adequate hydration. Living donors undergo annual renal function monitoring throughout their lives under the transplant centre's donor follow-up programme.